Publication: Does transient hypothyroxinemia influence metabolic bone disease of prematurity?
| dc.contributor.author | BEREKET, ABDULLAH | |
| dc.contributor.author | TOPUZOĞLU, AHMET | |
| dc.contributor.author | ÖZEK, EREN | |
| dc.contributor.authors | Demirel, Utku; Ozek, Eren; Bereket, Abdullah; Demirel, Bilge; Topuzoglu, Ahmet; Akman, Ipek | |
| dc.date.accessioned | 2022-03-12T18:11:35Z | |
| dc.date.accessioned | 2026-01-11T08:08:50Z | |
| dc.date.available | 2022-03-12T18:11:35Z | |
| dc.date.issued | 2013 | |
| dc.description.abstract | Objective: To investigate the relationship between Metabolic Bone Disease (MBD) and Transient Hypothyroxinemia of Prematurity (THOP). Method: One hundred twenty-four infants, born in Marmara University Hospital with a gestational age <= 34 weeks, were enrolled. Clinical features were recorded. Serum TSH, free T-4, total T-4, calcium, phosphorus and total Alkaline Phosphatase (ALP) levels were determined in the first and third postnatal weeks. MBD was defined as a phosphorus level <4.5 mg/dl and/or ALP >900 IU/l. THOP was defined as a serum free and/or total thyroxine level lower than -1 SD for gestational age at the 7th postnatal day. Result: THOP was diagnosed in nineteen (15.3%) patients. MBD was diagnosed in 52 (41.9%) at the 3rd month. Low birth weight, low gestational age and prolonged parenteral nutrition were associated with MBD. Multivariate analysis documented a significant relationship solely between MBD and gestational age. Conclusion: The risk of MBD does not increase significantly in babies with THOP. | |
| dc.identifier.doi | 10.3109/14767058.2013.804051 | |
| dc.identifier.eissn | 1476-4954 | |
| dc.identifier.issn | 1476-7058 | |
| dc.identifier.pubmed | 23672243 | |
| dc.identifier.uri | https://hdl.handle.net/11424/231463 | |
| dc.identifier.wos | WOS:000327321900016 | |
| dc.language.iso | eng | |
| dc.publisher | TAYLOR & FRANCIS LTD | |
| dc.relation.ispartof | JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE | |
| dc.rights | info:eu-repo/semantics/closedAccess | |
| dc.subject | Alkaline phosphatase | |
| dc.subject | metabolic bone disease | |
| dc.subject | prematurity | |
| dc.subject | thyroid hormones | |
| dc.subject | transient hypothyroxinemia | |
| dc.subject | SERUM THYROID-HORMONES | |
| dc.subject | BIRTH-WEIGHT INFANTS | |
| dc.subject | DEVELOPMENTAL-TRENDS | |
| dc.subject | HYPOTHYROIDISM | |
| dc.subject | FRACTURES | |
| dc.subject | GROWTH | |
| dc.subject | CORD | |
| dc.title | Does transient hypothyroxinemia influence metabolic bone disease of prematurity? | |
| dc.type | article | |
| dspace.entity.type | Publication | |
| oaire.citation.endPage | 1849 | |
| oaire.citation.issue | 18 | |
| oaire.citation.startPage | 1844 | |
| oaire.citation.title | JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE | |
| oaire.citation.volume | 26 |
